Neuropeptide treatment for dry eye and dry mouth syndromes
This technology is a combination of anti-inflammatory neuropeptides for topical treatment of dry eye and dry mouth syndromes.
Oxytocin, secretin, and vasopressin are already available individually as drug treatmentsTreatment targets underlying cause of dry eye and dry mouth syndromesCan be locally delivered to the affected areas (eyes or mouth)Can be formulated as either an aqueous solution or an ointmentCan be used in combination with other pharmaceutical agents
Topical treatment of dry eye and dry mouth Treatment for blepharitisTreatment for Sjogren’s syndromeProphylactic treatment of dry eye or dry mouth caused by drug-related side effects or in premenopausal womenCombination therapy with other active pharmaceutical agents for allergy treatmentResearch tool to study the inflammatory pathways in dry eye and dry mouth
None
美国
